Kenneth J. Snow, MD, MBA, joined the staff of the Joslin Clinic in Boston in 1994. He is currently the Acting Chief of Adult Diabetes and the Director of the Sexual Function Clinic. In addition, he is on the Endocrinology staff at the Beth Israel Deaconess Medical Center in Boston and is an Assistant Professor of Clinical Medicine at Harvard Medical School.

Dr. Snow received a Bachelors degree from the Massachusetts Institute of Technology in Boston, Massachusetts and earned his medical degree at the Johns Hopkins School of Medicine in Baltimore, Maryland. He performed his residency in Internal Medicine at Northwestern Memorial Hospital in Chicago. He then completed an endocrinology fellowship at the New England Medical Center Hospitals in Boston. This past year he completed an MBA degree at the University of Massachusetts.

Dr. Jerry Palmer is Professor of Medicine at the University of Washington, Director of the Division of Endocrinology, Metabolism and Nutrition at the Veterans Affairs Puget Sound Health Care System, and Director of the Diabetes Endocrinology Research Center (DERC) at the University of Washington. His research interests focus on type 1 diabetes and encompass both clinical/translational research and basic laboratory research. He was director of the DCCT clinical center and currently directs the DCCT/EDIC and the TRIGR clinical centers at the University of Washington. He is actively involved in TrialNet and directs the beta-cell function and the cellular immunoblotting core laboratories for this organization. His basic science laboratory, which previously focused on autoantibodies as markers of the type 1 diabetes (T1DM) disease process and was first to identify insulin autoantibodies in the preclinical period of T1DM, currently focuses on T-cell reactivity to islet antigens in T1DM. He is especially interested in type 1.5 diabetes or LADA, the autoimmune diabetes that occurs in patients with many of the characteristics of type 2 diabetes. He is a member of the ASCI and the AAP and currently sits on the NIDDK advisory council. He has been an associate editor of Diabetes, on the editorial boards of Diabetes Care and the Journal of Clinical Endocrinology and Metabolism, and is very frequently asked to review grants and manuscripts nationally and internationally. Because of his long-term interest in the prediction and more recently the prevention of T1DM, he is chairman of the protocol committee for the GAD vaccination prevention study that will be performed by TrialNet and is Principal Investigator of the recently initiated United States registration trial of GAD vaccination in recently diagnosed T1DM patients.

Dr. Rolla earned his MD at the Facultad de Medicina of the Universidad Catolica de Cordoba, the oldest private university in Argentina. He completed his residency in Internal Medicine at New England Deaconess Hospital and fellowships in Endocrinology, Diabetes & Metabolism at New England Deaconess Hospital and Joslin Diabetes Center. Dr. Rolla is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism. He speaks four languages and currently serves as Assistant Clinical Professor of Medicine at both Harvard Medical School and Tufts University School of Medicine in addition to seeing patients at Beth Israel Deaconess Medical Center in Boston.

Ms. Segal earned her Doctor of Pharmacy at Drake University, completed her pharmacy practice residency at the Medical Center at Princeton and her primary care residency at the Medical University of South Carolina. She also completed the General Clinical Research Center Scholars Program at University of New Mexico School of Medicine. In addition to her practice as a Clinical Pharmacist at Joslin Diabetes Center, Ms. Segal is also Associate Professor of Pharmacy Practice at Massachusetts College of Pharmacy & Health Sciences where she teaches Endocrinology, Complementary & Alternative Medicine, and Advanced Clinical Skills.

Director of Medical Affairs for Professional Education, Enrique Caballero, MD, is a practicing physician in the Joslin Clinic and an Assistant Professor of Medicine at Harvard Medical School. His CME responsibilities include project development, oversight of educational content, core slide development for educational activities, and oversight of activity evaluation and Educational Impact Assessments. He is a nationally and internationally known speaker on clinical diabetes, diabetes complications, and diabetes in minority populations, and has been a speaker at many live Joslin CME activities. Dr. Caballero has participated as a co-investigator for the National Diabetes Prevention Program (DPP) and the Action for Health in Diabetes (Look AHEAD) project, both supported by the National Institutes of Health, and has authored multiple original articles and book chapters. Dr. Caballero is a member of the American Diabetes Association, the Latin American Diabetes Association, and the European Association for the Study of Diabetes. Dr. Caballero also directs the Joslin Latino Diabetes Initiative and serves on the CME Advisory Committee.